AEG-41174
WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#:200110
CAS#:NONE
Description:AEG-41174 is a novel, non-ATP competitive, small molecule tyrosine kinase inhibitor targeting therapeutically significant kinases including JAK2 and Bcr-Abl, and is currently in a Phase 1 clinical trial (hematological malignancies).
Price and Availability
AEG-41174,is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.
Chemical Structure
Theoretical Analysis
MedKoo Cat#: 200110Name: AEG-41174CAS#: NONEChemical Formula: Exact Mass: Molecular Weight: Elemental Analysis:
Synonym:AEG41174; AEG 41174; AEG-41174
IUPAC/Chemical Name:NONE
Technical Data
Additional Information
AEG41174 is a novel, non-ATP competitive, small molecule tyrosine kinase inhibitor targeting therapeutically significant kinases including JAK2 and Bcr-Abl, and is currently in a Phase 1 clinical trial. (hematological malignancies)
